glp 1 compounding update FDA says that the GLP-1 shortage is over Despite FDA ruling, compounded GLP-1s

Complex: Bacillus Coagulans LactoSpore, Bacillus Subtillis DE111, Bacillus clausii

Semaglutide delays 4-hour gastric emptying in women with polycystic ovary syndrome and obesity

Retrieved March 10, 2026, from The four states that removed coverage of GLP-1 AOMs for weight loss collectively spent approximately $2.5 billion on Wegovy, Zepbound, and Saxenda in a 30-month span, on a gross basis for all indications

People using GLP-1s for weight loss are twice as likely to have a high income, whereas those using GLP-1s for diabetes control tend to be less well-off on average

doi: 10.2337/dc12-2454 217 ReuschJStewartMWPerkinsCMCirkelDTYeJPerryCRet al